Efficacy of Neoadjuvant Therapy With Trastuzumab Concurrent With Anthracycline- And Nonanthracycline-Based Regimens for HER2-positive Breast Cancer
Cancer - United States
doi 10.1002/cncr.26555
Full Text
Open PDFAbstract
Available in full text
Date
September 27, 2011
Authors
Publisher
Wiley